Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study.

被引：9
|
作者：
Giaccone, Giuseppe
Thompson, Jillian
McGuire, Colleen
Manning, Maria
Kallakury, Bhaskar
Chahine, Joeffrey J.
Subramaniam, Deepa Suresh
Liu, Stephen V.
Gibney, Geoffrey Thomas
Kim, Chul
McCutcheon, Justine N.
机构：
[1] Georgetown Univ, Washington, DC USA
[2] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[3] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[4] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
[5] NIH, NCI, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.8573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8573
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Phase II trial of nintedanib in patients with recurrent or metastatic salivary gland cancer: A multicenter phase II study.
    Kim, Youjin
    Lee, Su Jin
    Park, Keunchil
    Lee, Se-hoon
    Sun, Jong Mu
    Keam, Bhumsuk
    An, Ho Jung
    Cho, Jae Yong
    Kim, Jin-Soo
    Lee, Ha-young
    Kim, HyeRyun
    Lee, Kyoung Eun
    Choi, Moon Young
    Lee, Ki Hyeong
    Ahn, Myung-Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study.
    Nastoupil, Loretta J.
    Westin, Jason R.
    Fowler, Nathan Hale
    Fanale, Michelle A.
    Samaniego, Felipe
    Oki, Yasuhiro
    Obi, Chizobam
    Cao, JingJing
    Cheng, Xiaoyun
    Ma, Man Chun John
    Wang, Zhigiang
    Chu, Fuliang
    Feng, Lei
    Zhou, Shouhao
    Davis, Richard Eric
    Neelapu, Sattva Swarup
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Phase II study of combination pembrolizumab and olaparib in patients with advanced cholangiocarcinoma: Interim results
    Yin, Chao
    Armstrong, Samantha Ann
    Agarwal, Seema
    Wang, Hongkun
    Noel, Marcus Smith
    Weinberg, Benjamin Adam
    Marshall, John
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [34] Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
    Slomovitz, Brian M.
    Jiang, Yunyun
    Yates, Melinda S.
    Soliman, Pamela T.
    Johnston, Taren
    Nowakowski, Maureen
    Levenback, Charles
    Zhang, Qian
    Ring, Kari
    Munsell, Mark F.
    Gershenson, David M.
    Lu, Karen H.
    Coleman, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (08) : 930 - +
  • [35] Pembrolizumab for recurrent/metastatic cutaneous squamous cell carcinoma (cSCC): Efficacy and safety results from the phase II KEYNOTE-629 study
    Grob, J. J.
    Gonzalez Mendoza, R.
    Basset-Seguin, N.
    Vornicova, O.
    Schachter, J.
    Joshi, A.
    Meyer, N.
    Grange, F.
    Piulats, J. M.
    Bauman, J.
    Zhang, P.
    Gumuscu, B.
    Swaby, R. F.
    Hughes, B. G. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 908 - 908
  • [36] Gefitinib and radiation therapy for elderly patients with esophageal squanious cell carcinoma: Preliminary results of a phase II study.
    Xu, Yaping
    Yu, Xinmin
    Zheng, Yuanda
    Sun, Xiaojiang
    Wu, Wei
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study.
    Adamo, V
    Ferrandina, G
    Spada, M
    Ferrau, F
    Condemi, G
    Di Lullo, L
    Lorusso, D
    Rossello, R
    Garipoli, C
    Scambia, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 75S - 75S
  • [38] Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma
    Katsuya, Yuki
    Kitano, Shigehisa
    Yamashita, Makiko
    Ouchi, Mayu
    Yagishita, Shigehiro
    Hamada, Akinobu
    Nakamura, Hiromi
    Hosoda, Fumie
    Shibata, Tatsuhiro
    Motoi, Noriko
    Nakayama, Takayuki
    Seto, Takashi
    Umemura, Shigeki
    Hosomi, Yukio
    Satouchi, Miyako
    Nishio, Makoto
    Kozuki, Toshiyuki
    Hida, Toyoaki
    Ohe, Yuichiro
    Horinouchi, Hidehito
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [39] Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma (AHCC): Results of a phase II study.
    Taieb, J
    Mansourbakht, T
    Ducreux, M
    Bonyhay, L
    De Baere, T
    Delgado, M
    Poynard, T
    Boige, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 334S - 334S
  • [40] Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
    Matulonis, U. A.
    Shapira-Frommer, R.
    Santin, A. D.
    Lisyanskaya, A. S.
    Pignata, S.
    Vergote, I
    Raspagliesi, F.
    Sonke, G. S.
    Birrer, M.
    Provencher, D. M.
    Sehouli, J.
    Colombo, N.
    Gonzalez-Martin, A.
    Oaknin, A.
    Ottevanger, P. B.
    Rudaitis, V
    Katchar, K.
    Wu, H.
    Keefe, S.
    Ruman, J.
    Ledermann, J. A.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1080 - 1087
12345